ESR1 and endometrial cancer: Current drugs used for the treatment of osteoporosis may exert adverse side effects as jaw osteonecrosis or upper gastrointestinal diseases for bisphosphonates [33], [34] and increased risks of endometrial cancer for selective estrogen receptor modulators (SERMs) [35].